R S Gray

3.1k total citations · 1 hit paper
40 papers, 2.4k citations indexed

About

R S Gray is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, R S Gray has authored 40 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Genetics and 15 papers in Surgery. Recurrent topics in R S Gray's work include Diabetes and associated disorders (17 papers), Diabetes Management and Research (16 papers) and Pancreatic function and diabetes (13 papers). R S Gray is often cited by papers focused on Diabetes and associated disorders (17 papers), Diabetes Management and Research (16 papers) and Pancreatic function and diabetes (13 papers). R S Gray collaborates with scholars based in United Kingdom, United States and Jamaica. R S Gray's co-authors include Jerrold M. Olefsky, Orville Kolterman, J A Scarlett, Justin W. Griffin, W J Irvine, C J McCallum, L. J. P. Duncan, J Insel, Linda D. Cowan and Barbara V. Howard and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

R S Gray

40 papers receiving 2.2k citations

Hit Papers

Receptor and postreceptor defects contribute to the insul... 1981 2026 1996 2011 1981 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R S Gray United Kingdom 22 1.5k 954 731 602 461 40 2.4k
Timo Kuusi Finland 25 1.4k 0.9× 637 0.7× 295 0.4× 355 0.6× 322 0.7× 47 2.5k
E. Windler Germany 25 1.3k 0.8× 1.2k 1.2× 335 0.5× 807 1.3× 347 0.8× 82 3.1k
Ole Hother‐Nielsen Denmark 26 924 0.6× 493 0.5× 221 0.3× 878 1.5× 751 1.6× 52 2.0k
Hiroshi Kajio Japan 25 1.0k 0.7× 753 0.8× 557 0.8× 575 1.0× 316 0.7× 140 2.5k
Rochelle L Chaiken United States 21 969 0.6× 418 0.4× 389 0.5× 284 0.5× 477 1.0× 28 1.8k
Hans Jansen Netherlands 27 1.1k 0.7× 853 0.9× 237 0.3× 353 0.6× 192 0.4× 60 2.0k
S. Motoyoshi Japan 7 1.8k 1.2× 397 0.4× 241 0.3× 497 0.8× 240 0.5× 12 2.5k
Barry Gumbiner United States 25 1.1k 0.7× 1.3k 1.4× 135 0.2× 597 1.0× 635 1.4× 51 2.7k
Avedis K. Khachadurian United States 25 558 0.4× 595 0.6× 188 0.3× 373 0.6× 359 0.8× 60 1.8k
Yoshifumi Saisho Japan 29 2.1k 1.4× 2.2k 2.3× 1.2k 1.7× 1.0k 1.7× 497 1.1× 111 3.9k

Countries citing papers authored by R S Gray

Since Specialization
Citations

This map shows the geographic impact of R S Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R S Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R S Gray more than expected).

Fields of papers citing papers by R S Gray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R S Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R S Gray. The network helps show where R S Gray may publish in the future.

Co-authorship network of co-authors of R S Gray

This figure shows the co-authorship network connecting the top 25 collaborators of R S Gray. A scholar is included among the top collaborators of R S Gray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R S Gray. R S Gray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
North, Kari E., Ken Williams, Jeff T. Williams, et al.. (2003). Evidence for Genetic Factors Underlying the Insulin Resistance Syndrome in American Indians. Obesity Research. 11(12). 1444–1448. 16 indexed citations
3.
Hu, Dongsheng, R S Gray, Kathleen A. Jablonski, et al.. (2000). Effects of Obesity and Body Fat Distribution on Lipids and Lipoproteins in Nondiabetic American Indians: The Strong Heart Study. Obesity Research. 8(6). 411–421. 90 indexed citations
4.
Gray, R S, et al.. (1998). Risk Factor Clustering in the Insulin Resistance Syndrome: The Strong Heart Study. American Journal of Epidemiology. 148(9). 869–878. 136 indexed citations
5.
Sasaki, Truman M., et al.. (1998). SUCCESSFUL LONG-TERM KIDNEY-PANCREAS TRANSPLANTS IN DIABETIC PATIENTS WITH HIGH C-PEPTIDE LEVELS. Transplantation. 65(11). 1510–1512. 35 indexed citations
6.
Gray, R S, David C. Robbins, Wenyu Wang, et al.. (1997). Relation of LDL Size to the Insulin Resistance Syndrome and Coronary Heart Disease in American Indians. Arteriosclerosis Thrombosis and Vascular Biology. 17(11). 2713–2720. 84 indexed citations
7.
Collier, A., et al.. (1988). Effectiveness of acarbose, an alpha-glucosidase inhibitor, in uncontrolled non-obese non-insulin dependent diabetes. European Journal of Clinical Pharmacology. 34(1). 51–53. 19 indexed citations
8.
Gray, R S, Peter J. Cowan, Umberto Di Mario, et al.. (1985). Influence of insulin antibodies on pharmacokinetics and bioavailability of recombinant human and highly purified beef insulins in insulin dependent diabetics.. BMJ. 290(6483). 1687–1691. 35 indexed citations
9.
Gould, I.M., R S Gray, S. J. Urbaniak, R A Elton, & L. J. P. Duncan. (1985). Vitiligo in diabetes mellitus. British Journal of Dermatology. 113(2). 153–155. 36 indexed citations
10.
Gray, R S, Peter J. Cowan, J M Steel, et al.. (1984). Insulin Action and Pharmacokinetics in Insulin Treated Diabetics during the Third Trimester of Pregnancy. Diabetic Medicine. 1(4). 273–278. 13 indexed citations
11.
Gray, R S, Peter J. Cowan, L. J. P. Duncan, & B. F. Clarke. (1984). A comparison of the biological actions and pharmacokinetics of intravenously infused highly purified beef and biosynthetic human insulins in normal man.. PubMed. 10(3). 188–93. 2 indexed citations
12.
Kolterman, Orville, R S Gray, Galina Shapiro, et al.. (1984). The Acute and Chronic Effects of Sulfonylurea Therapy in Type II Diabetic Subjects. Diabetes. 33(4). 346–354. 181 indexed citations
13.
Gray, R S, D. Q. Borsey, W J Irvine, J. Seth, & B. F. Clarke. (1983). NATURAL HISTORY OF THYROID FUNCTION IN DIABETICS WITH IMPAIRED THYROID RESERVE: A FOUR YEAR CONTROLLED STUDY. Clinical Endocrinology. 19(4). 445–451. 20 indexed citations
14.
Kurtz, A. B., et al.. (1983). Circulating IgG antibody to protamine in patients treated with protamine-insulins. Diabetologia. 25(4). 322–4. 28 indexed citations
15.
Gray, R S, J A Scarlett, Justin W. Griffin, Jerrold M. Olefsky, & Orville Kolterman. (1982). In Vivo Deactivation of Peripheral, Hepatic, and Pancreatic Insulin Action in Man. Diabetes. 31(10). 929–936. 41 indexed citations
16.
Gray, R S, D. Q. Borsey, D M Fraser, et al.. (1981). Diabetic control in patients treated with once or twice-daily insulin injections, including a comparison of conventional beef and highly purified pork insulins. Diabetologia. 21(3). 206–10. 5 indexed citations
17.
Gibbs, W. N., R S Gray, & Michael Lowry. (1979). Glucose‐6‐Phosphate Dehydrogenase Deficiency and Neonatal Jaundice in Jamaica. British Journal of Haematology. 43(2). 263–274. 28 indexed citations
18.
Irvine, W J, C J McCallum, R S Gray, et al.. (1977). Pancreatic Islet-cell Antibodies in Diabetes Mellitus Correlated with the Duration and Type of Diabetes, Coexistent Autoimmune Disease, and HLA Type. Diabetes. 26(2). 138–147. 203 indexed citations
19.
Morris, P. J., H Vaughan, C J McCallum, et al.. (1976). HLA and pancreatic islet cell antibodies in diabetes [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 2(3). 158–158. 3 indexed citations
20.
Irvine, W J, R S Gray, & C J McCallum. (1976). PANCREATIC ISLET-CELL ANTIBODY AS A MARKER FOR ASYMPTOMATIC AND LATENT DIABETES AND PREDIABETES. The Lancet. 308(7995). 1097–1102. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026